Improving Sleep and AD Biomarkers
This study is looking to see if a *dietary supplement* called citicoline can help with sleep and thinking skills, especially for people with **mild cognitive impairment (MCI)**, a condition where people have trouble with memory and thinking. The study will also check if citicoline affects special markers in the body related to **Alzheimer's Disease (AD)**, a brain disorder that affects memory and thinking. The study is a **double-blind** trial, meaning neither the participants nor the researchers know who is getting the actual supplement or a **placebo** (a pill that doesn’t have the supplement). Adults over 60 with MCI can join, but they can't participate if they have certain health problems or are taking certain medications. Participants will have their blood drawn to check for AD markers at the start and end of the study.
- Duration: The study involves baseline and follow-up visits.
- Compensation: Participants may receive compensation for their time.
- Risks: Minimal, but participants should not have allergies to citicoline or certain health issues.
Study details
NCT06029894
Emory University
22 June 2024
Not finding the right Trial?
,
You have contacted , on
Your message has been sent to the study team at ,
What happens next?
- You can expect the study team to contact you via email or phone in the next few days.
- Sign up as volunteer to help accelerate the development of new treatments and to get notified about similar trials.
You are contacting
Primary Contact
FAQs
Learn more about clinical trials
What is a clinical trial?
Why should I take part in a clinical trial?
How long does a clinical trial take place?
Do I get compensated for taking part in clinical trials?
How safe are clinical trials?
Study Definition
WikipediaAdd a private note
- Select a piece of text.
- Add notes visible only to you.
- Send it to people through a passcode protected link.